HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)

Market Cap	7.66B +41.1%
Revenue (ttm)	2.25B -7.5%
Net Income	293.04M +265.4%
EPS	0.13 +249.0%
Shares Out	2.23B
PE Ratio	26.95
Forward PE	31.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,727,408
Average Volume	94,998,909
Open	3.470
Previous Close	3.360
Day's Range	3.380 - 3.470
52-Week Range	2.120 - 4.080
Beta	0.17
RSI	56.93
Earnings Date	Apr 28, 2026

About SHE:002437

HARBIN GLORIA PHARMACEUTICALS Co., LTD engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. Its products include cardiovascular and cerebrovascular, musculoskeletal, vitamins, electrolyte, diabetes-lowering, analgesics, digestive system and metabolism, anti-infective, and anti-tumor drugs. Harbin Gloria Pharmaceuticals Co., Ltd was founded in 2000 and is based in Harbin, the People’s Republic of China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 2,703
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002437

Financial Performance

In 2024, SHE:002437's revenue was 2.44 billion, a decrease of -7.06% compared to the previous year's 2.63 billion. Earnings were 232.76 million, an increase of 93.43%.